Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by Crossref.
&NA;
2000.
Olanzapine: Deterioration of parkinsonian symptoms in an elderly patient: case report.
Reactions Weekly,
Vol. &NA;,
Issue. 790,
p.
8.
Tollefson, Gary D.
and
Taylor, Cindy C.
2000.
Olanzapine: Preclinical and Clinical Profiles of a Novel Antipsychotic Agent.
CNS Drug Reviews,
Vol. 6,
Issue. 4,
p.
303.
Conley, Robert R.
and
Kelly, Deanna L.
2001.
Treatment of the special patient with schizophrenia.
Dialogues in Clinical Neuroscience,
Vol. 3,
Issue. 2,
p.
123.
Wolters, Erik Ch.
and
Berendse, Henk W.
2001.
Management of psychosis in Parkinsonʼs disease.
Current Opinion in Neurology,
Vol. 14,
Issue. 4,
p.
499.
Giménez-Roldán, S
Mateo, D
Navarro, E
and
Ginés, M.M
2001.
Efficacy and safety of clozapine and olanzapine: an open-label study comparing two groups of Parkinson's disease patients with dopaminergic-induced psychosis.
Parkinsonism & Related Disorders,
Vol. 7,
Issue. 2,
p.
121.
Friedman, Joseph H.
and
Fernandez, Hubert H.
2002.
Atypical Antipsychotics in Parkinson-Sensitive Populations.
Journal of Geriatric Psychiatry and Neurology,
Vol. 15,
Issue. 3,
p.
156.
Nguyen, Nhan
Pradel, Vincent
Micallef, Joëlle
Montastruc, Jean-Louis
and
Blin, Olivier
2004.
Les syndromes parkinsoniens médicamenteux.
Therapies,
Vol. 59,
Issue. 1,
p.
105.
Ondo, William G.
Tintner, Ron
Dat Voung, Kevin
Lai, Dejian
and
Ringholz, George
2005.
Double‐blind, placebo‐controlled, unforced titration parallel trial of quetiapine for dopaminergic‐induced hallucinations in Parkinson's disease.
Movement Disorders,
Vol. 20,
Issue. 8,
p.
958.
Gareri, Pietro
De Fazio, Pasquale
De Fazio, Salvatore
Marigliano, Norma
Ferreri Ibbadu, Guido
and
De Sarro, Giovambattista
2006.
Adverse Effects of Atypical Antipsychotics in the Elderly.
Drugs & Aging,
Vol. 23,
Issue. 12,
p.
937.
Dastgheib, Seyed Ali
Ghanizadeh, Ahmad
Mowla, Arash
and
Khajeian, Abdul Mohammad
2009.
Does Electroconvulsive Therapy Afford Protection Against Olanzapine-Induced Parkinsonism? A Case Report.
The Journal of ECT,
Vol. 25,
Issue. 2,
p.
146.
Huot, Philippe
Fox, Susan H.
and
Brotchie, Jonathan M.
2011.
The serotonergic system in Parkinson's disease.
Progress in Neurobiology,
Vol. 95,
Issue. 2,
p.
163.
Khammassi, Naziha
Ben Mansour, Amel
Abdelhedi, Haykel
and
Cherif, Ouahida
2012.
Les effets indésirables des psychotropes chez le sujet âgé : étude rétrospective de 35 cas.
Annales Médico-psychologiques, revue psychiatrique,
Vol. 170,
Issue. 4,
p.
251.
QUELHAS, ROSA
2013.
Psychiatric Care in Parkinson’s Disease.
Journal of Psychiatric Practice,
Vol. 19,
Issue. 2,
p.
118.
Comments
No Comments have been published for this article.